287 related articles for article (PubMed ID: 10864664)
21. An alternative pathway for transcription initiation involving TFII-I.
Roy AL; Malik S; Meisterernst M; Roeder RG
Nature; 1993 Sep; 365(6444):355-9. PubMed ID: 8377828
[TBL] [Abstract][Full Text] [Related]
22. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16.
Tan SH; Baker CC; Stünkel W; Bernard HU
Virology; 2003 Jan; 305(2):486-501. PubMed ID: 12573593
[TBL] [Abstract][Full Text] [Related]
23. TFII is required for transcription of the naturally TATA-less but initiator-containing Vbeta promoter.
Manzano-Winkler B; Novina CD; Roy AL
J Biol Chem; 1996 May; 271(20):12076-81. PubMed ID: 8662630
[TBL] [Abstract][Full Text] [Related]
24. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
Zachow KR; Conklin KF
J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of the transcription control region located within the avian retroviral long terminal repeat.
Cullen BR; Raymond K; Ju G
Mol Cell Biol; 1985 Mar; 5(3):438-47. PubMed ID: 2985953
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human beta-globin downstream promoter region.
Leach KM; Vieira KF; Kang SH; Aslanian A; Teichmann M; Roeder RG; Bungert J
Nucleic Acids Res; 2003 Feb; 31(4):1292-301. PubMed ID: 12582249
[TBL] [Abstract][Full Text] [Related]
27. Cloning of Rous sarcoma virus enhancer factor genes. I. Evidence that RSV-EF-I is related to Y-box (inverted CCAAT) binding proteins and binds to multiple motifs in the RSV enhancer.
Kandala JC; Guntaka RV
Virology; 1994 Feb; 198(2):514-23. PubMed ID: 8291233
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
[TBL] [Abstract][Full Text] [Related]
29. TFII-I regulates Vbeta promoter activity through an initiator element.
Cheriyath V; Novina CD; Roy AL
Mol Cell Biol; 1998 Aug; 18(8):4444-54. PubMed ID: 9671454
[TBL] [Abstract][Full Text] [Related]
30. The serum unresponsive Rous sarcoma virus promoter sustains a high serum response factor-dependent transcription in vitro.
Trouche D; Grigoriev M; Robin P; Harel-Bellan A
Biochem Biophys Res Commun; 1993 Oct; 196(2):611-8. PubMed ID: 8240335
[TBL] [Abstract][Full Text] [Related]
31. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
Goodwin GH
J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of the 5'-flanking region for the human topoisomerase III gene.
Kim JC; Yoon JB; Koo HS; Chung IK
J Biol Chem; 1998 Oct; 273(40):26130-7. PubMed ID: 9748294
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
Ryden TA; de Mars M; Beemon K
J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of a DNA polymerase beta promoter initiator element-binding transcription factor from bovine testis.
He F; Narayan S; Wilson SH
Biochemistry; 1996 Feb; 35(6):1775-82. PubMed ID: 8639658
[TBL] [Abstract][Full Text] [Related]
35. In simple synthetic promoters YY1-induced DNA bending is important in transcription activation and repression.
Kim J; Shapiro DJ
Nucleic Acids Res; 1996 Nov; 24(21):4341-8. PubMed ID: 8932392
[TBL] [Abstract][Full Text] [Related]
36. A cis-acting element in Rous sarcoma virus long terminal repeat required for promoter repression by HeLa nuclear protein p21.
Yeh CH; Shatkin AJ
J Biol Chem; 1995 Jun; 270(26):15815-20. PubMed ID: 7797584
[TBL] [Abstract][Full Text] [Related]
37. Sp1 binding sites inserted into the rous sarcoma virus long terminal repeat enhance LTR-driven gene expression.
Machon O; Strmen V; Hejnar J; Geryk J; Svoboda J
Gene; 1998 Feb; 208(1):73-82. PubMed ID: 9479051
[TBL] [Abstract][Full Text] [Related]
38. Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y.
Faber M; Sealy L
J Biol Chem; 1990 Dec; 265(36):22243-54. PubMed ID: 2176209
[TBL] [Abstract][Full Text] [Related]
39. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
[TBL] [Abstract][Full Text] [Related]
40. The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator.
Bogomolski-Yahalom V; Klein A; Greenblat I; Haviv Y; Tur-Kaspa R
Virus Res; 1997 May; 49(1):1-7. PubMed ID: 9178491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
